IBA
Manufacturing · Belgium · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Chemin Du Cyclotron 3, Louvain-la-Neuve,...Phone Number
+32 10475811Website
www.iba-worldwide.comRevenue
$684.8 MillionStock Symbol
IBABIndustry
About IBA
IBA Org Chart
Is IBA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at IBA
Check if IBA has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on IBA recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when IBA launches new products
Click to see if IBA had a recent Job posting/layoffs
Check out if IBA is spiking on competitors!
Funding: Get notified immidiatlly once IBA has new funding data
IBA, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
IBA is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
IBA is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about IBA.
IBA Tech Stack
A closer look at the technologies used by IBA
Most Recent Scoops
IBA News & Media
IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions
Louvain-La-Neuve, Belgium, June 08, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces the signing of a contract with Duke University Health System for the installation of two Proteus®ONE1 compact proton therapy solutions at the Duke Proton Center in Durham, NC, USA.IBA – ACQUISITION OF OWN SHARES
Louvain-la-Neuve, Belgium, May 26th, 2026 – 6 PM CEST – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA”) hereby discloses information in relation to its share buyback program announced on February 2nd, 2026.First quarter 2026 update: starting the year on track, with product innovation progress
Louvain-la-Neuve, Belgium, 21 May 2026 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, shares its business update for the first quarter of 2026.IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
Louvain-la-Neuve, Belgium, May 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, announced today the launch of Rhodotron® LITE, a new low-power X-ray accelerator. This launch expands IBA’s industrial X-ray portfolio into the low-capacity segment, enabling a broader range of operators to access X-ray irradiation technology at a time when supply security, operational
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding IBA
IBA Group is a global leader in particle accelerator technology, designing and producing innovative solutions for medical and industrial applications. The company develops equipment for cancer diagnosis and treatment, as well as industrial uses like sterilization of medical devices. With a focus on improving health outcomes, IBA supports hospitals... Read More